Literature DB >> 14655136

Expression of connexin 43 in breast cancer in comparison with mammary dysplasia and the normal mammary gland.

Luiza Kańczuga-Koda1, Mariola Sulkowska, Mariusz Koda, Joanna Reszeć, Waldemar Famulski, Marek Baltaziak, Stanisław Sulkowski.   

Abstract

Gap junctional intercellular communication (GJIC) plays a critical role in tissue development and differentiation and probably in carcinogenesis. The purpose of the study was to evaluate the expression and localisation of Cx43 in 40 cases of mammary dysplasia and 29 cases of breast cancer (without primary chemotherapy). The tissue sections were investigated for Cx43 expression by immunohistochemistry. In the normal mammary gland there was an intercellular, punctate staining pattern, mainly between myoepithelial cells, characteristic of functional gap junctions. In dysplasias there was mainly mixed (cytoplasmic and intercellular) staining and in most cases of breast cancer we observed diffuse or granular, but cytoplasmic, staining of Cx43. Our results demonstrated that expression of Cx43 in dysplasias and breast cancer is changed and GJIC is probably impaired because of disruption of functional gap junction formation especially between breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14655136

Source DB:  PubMed          Journal:  Folia Morphol (Warsz)        ISSN: 0015-5659            Impact factor:   1.183


  17 in total

Review 1.  Gap Junctions and Wnt Signaling in the Mammary Gland: a Cross-Talk?

Authors:  Sabreen F Fostok; Mirvat El-Sibai; Marwan El-Sabban; Rabih S Talhouk
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

2.  Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer.

Authors:  Luiza Kanczuga-Koda; Stanislaw Sulkowski; Mariusz Koda; Elzbieta Skrzydlewska; Mariola Sulkowska
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

3.  Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.

Authors:  L Kanczuga-Koda; S Sulkowski; A Lenczewski; M Koda; A Wincewicz; M Baltaziak; M Sulkowska
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

Review 4.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

5.  Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo.

Authors:  Diana B Burr; Samuel A Molina; Debarshi Banerjee; Derek M Low; Dolores J Takemoto
Journal:  Exp Eye Res       Date:  2011-02-12       Impact factor: 3.467

6.  Connexin 43 maintains tissue polarity and regulates mitotic spindle orientation in the breast epithelium.

Authors:  D Bazzoun; H A Adissu; L Wang; A Urazaev; I Tenvooren; S F Fostok; S Chittiboyina; J Sturgis; K Hodges; G Chandramouly; P-A Vidi; R S Talhouk; S A Lelièvre
Journal:  J Cell Sci       Date:  2019-05-16       Impact factor: 5.285

7.  A novel role of gap junction connexin46 protein to protect breast tumors from hypoxia.

Authors:  Debarshi Banerjee; Gunjan Gakhar; Dan Madgwick; Amy Hurt; Dolores Takemoto; Thu Annelise Nguyen
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 8.  Connexins and gap junctions in mammary gland development and breast cancer progression.

Authors:  Elizabeth McLachlan; Qing Shao; Dale W Laird
Journal:  J Membr Biol       Date:  2007-07-28       Impact factor: 1.843

9.  Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1.

Authors:  Christina L Grek; Joshua Matthew Rhett; Jaclynn S Bruce; Melissa A Abt; Gautam S Ghatnekar; Elizabeth S Yeh
Journal:  BMC Cancer       Date:  2015-04-03       Impact factor: 4.430

10.  Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration.

Authors:  Elizabeth S Yeh; Christina J Williams; Carly Bess Williams; Ingrid V Bonilla; Nancy Klauber-DeMore; Stephanie L Phillips
Journal:  Oncotarget       Date:  2017-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.